Subsequently, A mouse model study has shown that COX2 inhibitors can induce tumor cell apoptosis and anti-proliferative effects by reducing the expression of VEGF-C and inhibiting tumor lymphangiogenesis, thus exhibiting significant anti-tumor activity [127]. The gene discussed is VEGFC; the disease is neoplasm.